1.11
                                            Schlusskurs vom Vortag:
              $1.10
            Offen:
              $1.11
            24-Stunden-Volumen:
                85,622
            Relative Volume:
              0.09
            Marktkapitalisierung:
                $95.59M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-21.65M
            KGV:
              -3.3424
            EPS:
                -0.3321
            Netto-Cashflow:
                $-15.84M
            1W Leistung:
              -6.54%
            1M Leistung:
              +3.94%
            6M Leistung:
                +1.11%
            1J Leistung:
              -38.21%
            Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Vergleichen Sie CRDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                CRDL
                            
                             Cardiol Therapeutics Inc | 1.1122 | 104.64M | 0 | -21.65M | -15.84M | -0.3321 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 142.89 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.42 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.245 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.11 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 447.46 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy | 
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy | 
| 2024-06-26 | Eingeleitet | ROTH MKM | Buy | 
| 2024-04-22 | Eingeleitet | H.C. Wainwright | Buy | 
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Is it time to cut losses on Cardiol Therapeutics Inc.Market Movement Recap & Safe Entry Momentum Tips - newser.com
Key metrics from Cardiol Therapeutics Inc.’s quarterly dataQuarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
What market sentiment indicators show for Cardiol Therapeutics Inc. (CT9) stockPortfolio Update Report & Verified Technical Trade Signals - newser.com
How Cardiol Therapeutics Inc. stock reacts to inflationary pressuresMarket Activity Report & Free Daily Entry Point Trade Alerts - newser.com
Using Python tools to backtest Cardiol Therapeutics Inc. strategies2025 Year in Review & Daily Stock Trend Reports - newser.com
How Cardiol Therapeutics Inc. stock responds to policy changesJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
How Cardiol Therapeutics Inc. stock benefits from tech adoptionFed Meeting & Advanced Technical Analysis Signals - newser.com
Can technical indicators confirm Cardiol Therapeutics Inc.’s reversalEarnings Beat & Safe Entry Zone Identification - newser.com
Is Cardiol Therapeutics Inc. stock dividend yield sustainableBreakout Watch & Risk Controlled Swing Trade Alerts - newser.com
How to Take Advantage of moves in (CRDL) (CRDL:CA) - news.stocktradersdaily.com
Why Cardiol Therapeutics Inc. stock is seen as undervaluedJuly 2025 Levels & Reliable Breakout Forecasts - newser.com
Advanced analytics toolkit walkthrough for Cardiol Therapeutics Inc.July 2025 Recap & Verified Chart Pattern Trade Signals - newser.com
Cardiol Therapeutics’ Phase-3 Trial: A Potential Game-Changer in Recurrent Pericarditis Treatment - MSN
Top chart patterns to watch in Cardiol Therapeutics Inc.Quarterly Earnings Report & Safe Entry Point Alerts - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock see valuation expansionMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Is Cardiol Therapeutics Inc. stock poised for growthMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
Is this a good reentry point in Cardiol Therapeutics Inc.Weekly Stock Summary & Expert Verified Movement Alerts - newser.com
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
What insider purchases suggest about Cardiol Therapeutics Inc. (CT9) stockJuly 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
Historical volatility pattern of Cardiol Therapeutics Inc. visualized2025 AllTime Highs & Weekly High Return Opportunities - newser.com
How Cardiol Therapeutics Inc. stock reacts to bond yieldsQuarterly Performance Summary & Long-Term Safe Return Strategies - newser.com
Full technical analysis of Cardiol Therapeutics Inc. stock2025 Top Decliners & Growth Focused Stock Reports - newser.com
Real time social sentiment graph for Cardiol Therapeutics Inc.Options Play & Free Growth Oriented Trading Recommendations - newser.com
Is Cardiol Therapeutics Inc. (CT9) stock undervalued at current priceQuarterly Risk Review & Entry Point Strategy Guides - Fundação Cultural do Pará
Can Cardiol Therapeutics Inc. stock beat market expectations this quarter2025 Historical Comparison & Technical Entry and Exit Alerts - Fundação Cultural do Pará
Is Cardiol Therapeutics Inc. stock supported by strong fundamentalsPortfolio Growth Summary & Growth Focused Investment Plans - Fundação Cultural do Pará
Cardiol Therapeutics Raises $16 Million Through Recent Securities Distribution - TipRanks
(CRDL) Stock Trading Blueprint (CRDL:CA) - news.stocktradersdaily.com
Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App